The New Carotid Braided Stent CASPERTM RX. Single center experience in 50 cases

• Main Authors: Cabral de Andrade G (Author), Lesczynski A (Author), Clímaco VM (Author), Pereira ER (Author)
• Format: Book
• Published: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2020-05-15.
• Subjects: Research Article
• Online Access: Connect to this object online.

Summary

<p>Purpose: Carotid stenosis, as well as dissections and pseudo dissecting aneurysms are etiological factors of Ischemic stroke. A new braided double-layer Nickel titanium Stent CASPERTMRX has super elasticity, shape-memory properties, combined with re-sheathable and repositionable, improving placement accuracy in a closed cell with flow diversion capability. To evaluate in clinical implant behavicor of in many different pathologies. </p><p>Materials and methods: It was implanted 53 CASPER-RX stents in 50 lesions (average age of 67 years; 29 men and 21 women) in different pathologies, high-grade symptomatic internal carotid artery stenosis in 43(86%) patients; and dissection in 7(4%) being: 4 dissecting pseudo aneurysms, 2 sub endothelial spontaneous dissections and 1 sub endothelial iatrogenic dissection. In all patients we used dual antiplatelet therapy, before treatment. </p><p>Results: Technical success achieved in all patients and complication rate (4%) and a 0% rate of neurological complications at 30 days. No stroke minor or restenosis after 6 months ultrasound or CT Scan examination FU. </p><p>Conclusion: CASPER™RX Stent conforms to tortuous anatomy, good wall apposition and a good conformation in tapered ICA-CCA segments in re sheathable delivery system. The very closed cells have a good result as a flow diverter. Technical success was achieved in all patients without clinical complications. However, we need long-term follow up to better assess the efficiency of this new device.</p>

DOI

10.17352/2455-2976.000127